These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 38287717
1. Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: Insights from the China health and retirement longitudinal study. Xiao D, Sun H, Chen L, Li X, Huo H, Zhou G, Zhang M, He B. Diabetes Metab Res Rev; 2024 Jan; 40(1):e3764. PubMed ID: 38287717 [Abstract] [Full Text] [Related]
8. Association of adiposity indicators with cardiometabolic multimorbidity risk in hypertensive patients: a large cross-sectional study. Dong T, Lin W, Zhou Q, Yang Y, Liu X, Chen J, Liu H, Zhang C. Front Endocrinol (Lausanne); 2024 Jan; 15():1302296. PubMed ID: 38577567 [Abstract] [Full Text] [Related]
9. The effect of insulin resistance in the association between obesity and hypertension incidence among Chinese middle-aged and older adults: data from China health and retirement longitudinal study (CHARLS). Niu ZJ, Cui Y, Wei T, Dou M, Zheng BX, Deng G, Tian PX, Wang Y. Front Public Health; 2024 Jan; 12():1320918. PubMed ID: 38414903 [Abstract] [Full Text] [Related]
10. Comparison of obesity indicators for predicting cardiovascular risk factors and multimorbidity among the Chinese population based on ROC analysis. Feng X, Zhu J, Hua Z, Yao S, Tong H. Sci Rep; 2024 Sep 09; 14(1):20942. PubMed ID: 39251694 [Abstract] [Full Text] [Related]
11. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY. Xie X, Li Q, Zhang L, Ren W. Endocr Pract; 2018 Jan 09; 24(1):33-39. PubMed ID: 29144802 [Abstract] [Full Text] [Related]
12. Relationship of triglyceride-glucose index with cardiometabolic multi-morbidity in China: evidence from a national survey. Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. Diabetol Metab Syndr; 2023 Nov 06; 15(1):226. PubMed ID: 37926824 [Abstract] [Full Text] [Related]
13. Predicting hypertension by obesity- and lipid-related indices in mid-aged and elderly Chinese: a nationwide cohort study from the China Health and Retirement Longitudinal Study. Li Y, Gui J, Zhang X, Wang Y, Mei Y, Yang X, Liu H, Guo LL, Li J, Lei Y, Li X, Sun L, Yang L, Yuan T, Wang C, Zhang D, Wei H, Li J, Liu M, Hua Y, Zhang L. BMC Cardiovasc Disord; 2023 Apr 20; 23(1):201. PubMed ID: 37081416 [Abstract] [Full Text] [Related]
14. Association between Chinese visceral adiposity index and risk of stroke incidence in middle-aged and elderly Chinese population: evidence from a large national cohort study. Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. J Transl Med; 2023 Jul 31; 21(1):518. PubMed ID: 37525182 [Abstract] [Full Text] [Related]
15. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China. Huang R, Cheng Z, Jin X, Yu X, Yu J, Guo Y, Zong L, Sheng J, Liu X, Wang S. Ann Med; 2022 Dec 31; 54(1):622-632. PubMed ID: 35175162 [Abstract] [Full Text] [Related]
16. Association of adiposity indices with cardiometabolic multimorbidity among 101,973 chinese adults: a cross-sectional study. Qin X, Chen C, Wang J, Cai A, Feng X, Jiang X, Feng Y. BMC Cardiovasc Disord; 2023 Oct 21; 23(1):514. PubMed ID: 37865773 [Abstract] [Full Text] [Related]
19. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Li F, Wang Y, Shi B, Sun S, Wang S, Pang S, Wu X. Cardiovasc Diabetol; 2024 Jan 06; 23(1):16. PubMed ID: 38184577 [Abstract] [Full Text] [Related]